Arcus Biosciences, Inc. (NYSE: RCUS) last traded at $30.34, up 2.78% on the session. The quote above updates while this page is open; the figures below are drawn from Arcus Biosciences, Inc.’s own filings and are restated only when a new one is published.
Arcus Biosciences, Inc. trades on NYSE under the ticker RCUS. Its market capitalisation is $3.86 billion.
Valuation measures for Arcus Biosciences, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $3.86B |
|---|---|
| Price / sales | 33.02 |
| Price / book | 8.33 |
| Beta | 1.81 |
Trailing-twelve-month figures tagged in Arcus Biosciences, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $117.00M |
|---|---|
| Net income (TTM) | -$460.00M |
| EPS (TTM) | -$3.89 |
| Operating margin | -415.38% |
| Return on equity | -99.14% |
| Cash | $150.00M |
Range and volume for RCUS over the past 52 weeks.
| 52-week high | $31.74 |
|---|---|
| 52-week low | $10.07 |
| Volume | 890.8K |
| Average volume | 1.30M |
| Previous close | $29.52 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.